MedTrace Logo

Sources of the Variability of the Response to Fluindione in Elderly Patients (PREPA)

NCT00313469 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 152

Last updated 2011-08-25

No results posted yet for this study

Summary

We propose to study the pharmacokinetic (PK) and pharmacodynamic (PD) components of the response to fluindione, the main oral anticoagulant used in France, in patients over 80.

We expect to gain a better understanding of the role of age, nutritional status, genetic factors and drug interactions in the variability of the response to fluindione.

Conditions

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • GIS Institut de la Longévité

    collaborator UNKNOWN

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • France Mentré, MD, PhD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2008-04-30
Completion
2008-04-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00313469 on ClinicalTrials.gov